Marco H Hofmann
9PUBLICATIONS
83CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Nov 25, 2025
SOS1 inhibition suppresses the emergence of osimertinib resistance to generate a durable response in EGFR-mutant lung cancer.Brianna R Daley, Patricia L Theard, Jacob M Hughes
|Oct 22, 2024
SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung Adenocarcinoma.Brianna R Daley, Nancy E Sealover, Bridget A Finniff
|Aug 05, 2024
Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance.Venu Thatikonda, Hengyu Lyu, Sabine Jurado
|May 10, 2024
Reshaping the Tumor Microenvironment of KRASG12D Pancreatic Ductal Adenocarcinoma with Combined SOS1 and MEK Inhibition for Improved Immunotherapy Response.Robert J Norgard, Pratha Budhani, Sarah A O'Brien
|Jan 20, 2022
Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants.Marco H Hofmann, Daniel Gerlach, Sandra Misale
Pageof 2
Frequent Collaborators
4 joint publications
Kaja Kostyrko
4 joint publications
Daniel Gerlach
3 joint publications
Norbert Kraut
2 joint publications
Melanie Hinkel
2 joint publications
Jark Böttcher
2 joint publications
Peter Ettmayer
2 joint publications
Darryl B McConnell
2 joint publications
Brianna R Daley
2 joint publications
Timothy P Heffernan
2 joint publications
Mark Petronczki